904 - HOW PHARMACEUTICAL COMPANIES CIRCUMVENT RESTRICTIONS TO PROMOTION AND LOBBYING ¿ THE CASE OF NEW DRUGS IN PORTUGAL J.P. Perelman; M.L. Leite;